Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Selvita appoints Dr. Nicolas D. Beuzen as Chief Scientific Officer and Member of the Management Board

14 May 2008 - Selvita Sp. z o.o. announced the appointment of Dr. Nicolas D. Beuzen as its Chief Scientific Officer and Member of the Management Board. Dr. Beuzen will oversee all Selvita's drug research projects.
 
After the first experience in 2002 as a Strategic Database Manager at Sanofi Pasteur MSD, Dr Beuzen joined in 2003 OPi Pharmaceuticals (now EUSA) as Project Manager. His activities included work on pre-clinical onco-haematology drug candidates (monoclonal antibodies and small molecules) as well as stage II-IV development in onco-haematology, CNS and metabolism. In 2006 he moved to India as Project Coordinator at Ethypharm, where he managed an international cross-functional team on the 'New Drug Delivery' portfolio of the French company. He holds a PhD in Molecular Biology from the University of Glasgow (United Kingdom) , B.Sc. in Applied biology - biotechnology and protein engineering from London South Bank University (United Kingdom). He is also a graduate of Université Jean Moulin (Lyon III) in Lyons (France) where he obtained his DESS (eq. M.A.) degree in Marketing of pharmaceutical products.